Learn More
*Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information. †ACCF/AHA representative. ‡ACP representative. §ACCF/AHA Task Force on Practice Guidelines liaison. ʈACCF/AHA Task Force on Performance Measures liaison. ¶ACEP(More)
*Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information. SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart(More)
symbol by their name were included to provide additional content expertise apart from organizational representation. The writing committee gratefully acknowledges the memory of Robert W. Hobson II, MD, who died during the development of this document but contributed immensely to our understanding of extracranial carotid and vertebral artery disease. the(More)
  • Carole A Warnes, Roberta G Williams, Thomas M Bashore, Facc, John S Child, Heidi M Connolly +32 others
  • 2008
*Society of Thoracic Surgeons representative. †International Society for Adult Congenital Heart Disease representative. ‡Society for Cardiovascular Angiography and Interventions representative. §American Society of Echocardiography representative. ʈHeart Rhythm Society representative. ¶Canadian Cardiovascular Society representative. #Former Task Force(More)
*Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information. †ACCF/AHA representative. ‡ACP representative. §ACCF/AHA Task Force on Practice Guidelines liaison. ʈACCF/AHA Task Force on Performance Measures liaison. ¶ACEP(More)
  • 1